title: Implementation of genomic medicine in a health care delivery system: a value proposition?
abstract: The United States health care system is undergoing significant change and is seeking innovations in care delivery and reimbursement models that will lead to improved value for patients, providers, payers, and employers. Genomic medicine has the potential to be a disruptive innovation that if implemented intelligently can improve value. The article presents the perspective of the leaders of a large integrated healthcare delivery system regarding the decision to invest in implementation of genomic medicine.
authors.forename: Joanne E
authors.initials: JE
authors.lastname: Wade
authors.forename: David H
authors.initials: DH
authors.lastname: Ledbetter
authors.forename: Marc S
authors.initials: MS
authors.lastname: Williams
mesh_terms: D003695:Delivery of Health Care / Q000191:economics* / Q000379:methods*; D005826:Genetics, Medical / Q000191:economics* / Q000379:methods; D023281:Genomics / Q000191:economics* / Q000379:methods; D006801:Humans; D057285:Precision Medicine / Q000191:economics* / Q000379:methods / Q000639:trends; D014481:United States
keywords: genomic medicine; healthcare delivery; implementation; innovation; integrated healthcare delivery system; personalized medicine; reimbursement; value